Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population
This study in the intended-use population suggests that EG/EC is promising for BE screening. While future work is necessary to define its performance characteristics with more precision, this approach may provide a safe, accurate, and well-tolerated nonendoscopic alternative in high-risk patients.
Authors
- Lishan Aklog
- Sathya Jaganmohan
- Victoria T. Lee (ORCID: https://orcid.org/0009-0005-7128-2919)
- John C. Fang (ORCID: https://orcid.org/0000-0003-3274-3979)
- Brian J. deGuzman
- Patrick Yachimski (ORCID: https://orcid.org/0000-0002-2529-4397)
- Mohamed O. Othman (ORCID: https://orcid.org/0000-0002-5888-4334)
- Kenneth J. Chang (ORCID: https://orcid.org/0000-0001-9897-277X)
- Joseph Spataro (ORCID: https://orcid.org/0000-0001-8015-3821)
- Jawar Taunk
- Nicholas J. Shaheen
- Suman Verma
Institutions
- University of North Carolina at Chapel Hill (US)
- Baylor College of Medicine (US)
- University of Utah (US)
- University of California, Irvine Medical Center (US)
- Lucid Technologies (United States) (US)
- VA Central California Health Care System (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.14309/ajg.0000000000003238
- Citations
- 7
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.01